Xing-nao-sheng-jiang powder alleviates ischemic stroke in rats by inhibiting pyroptosis-related microglial ETosis: An emerging perspective on microglial ETosis
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.157887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Chang Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Guangdong Provincial Academy of Chinese Medical Sciences, …. Hauptthemen laut MEDLINE: Pyroptosis, Drugs, Chinese Herbal, Microglia, Ischemic Stroke. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou University.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Stroke imposes a substantial global health burden. Microglial pyroptosis promotes acute cerebral ischemia. Gasdermin D (GSDMD), the principal executor of pyroptosis, has been implicated in a newly characterized form of proinflammatory cell death known as extracellular trap death (ETosis). Thus, targeting GSDMD may represent a promising therapeutic strategy to mitigate ischemic stroke. Xing-nao-sheng-jiang powder (XNSJP) was demonstrated to inhibit GSDMD-mediated pyroptosis in cerebral ischemia-reperfusion injury (CIRI). Based on these findings, we hypothesize that XNSJP may inhibit pyroptosis-related ETosis by targeting the GSDMD, thereby alleviating neuroinflammation in CIRI. METHODS: We prepared the MCAO model in SD rats and evaluated the effects of XNSJP on anti-CIRI. The effects of XNSJP on microglia and neutrophil pyroptosis and ETosis were detected. The composition of XNSJP was identified using UPLC and MS/MS methods. RESULTS: UPLC identified the characteristic peaks of XNSJP's active ingredients. MS/MS and network pharmacology suggested that XNSJP has regulatory effects on atherosclerosis, coagulation, and inflammation. The XNSJP reduced the area of infarction. XNSJP could inhibit the caspase-1/11/GSDMD-mediated pyroptosis. Furthermore, XNSJP impeded microglial pyroptosis-related ETosis by GSDMD, as evidenced by the suppression of MPO, PAD4, and CitH3. We also confirmed that 24 h after CIRI, the ETosis marker CitH3 mainly co-localized with microglia. CONCLUSIONS: We confirmed that microglia are crucial contributors to ETosis in CIRI. Furthermore, we demonstrated that XNSJP inhibited microglial pyroptosis and ETosis against CIRI, which is closely related to the inhibition of GSDMD. Mechanistically, XNSJP inhibits caspase-1/11/GSDMD-mediated microglial pyroptosis and MPO/PAD4/CitH3-mediated microglial ETosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China. Electronic address: zhouchang6688@foxmail.com.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China. Electronic address: 3997976978@qq.com.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: 249986679@qq.com.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: 1743916084@qq.com.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: 2498264092@qq.com.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: 1322684344@qq.com.
Förderung
- The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
- Guangzhou University of Chinese Medicine
- Guangzhou University
Zitieren
APA
Zhou, C., Tang, Y., Lu, F., DU, C. H., Zhu, W. L., Chen, G. X., Xia, H., Zhao, M., Zheng, Z. Q., & Zhao, Y. Q. (2026). Xing-nao-sheng-jiang powder alleviates ischemic stroke in rats by inhibiting pyroptosis-related microglial ETosis: An emerging perspective on microglial ETosis. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.157887
Vancouver
Zhou C, Tang Y, Lu F, DU CH, Zhu WL, Chen GX, et al. Xing-nao-sheng-jiang powder alleviates ischemic stroke in rats by inhibiting pyroptosis-related microglial ETosis: An emerging perspective on microglial ETosis. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.157887
BibTeX
@article{Zhou2026,
author = {Zhou, Chang and Tang, Ye and Lu, Fuchang and DU, Cheng-Hao and Zhu, Wei-Liang and Chen, Gui-Xian and Xia, Hui and Zhao, Min and Zheng, Ze-Quan and Zhao, Yuan-Qi},
title = {Xing-nao-sheng-jiang powder alleviates ischemic stroke in rats by inhibiting pyroptosis-related microglial ETosis: An emerging perspective on microglial ETosis},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.157887}
}
EUVIMED